NEW YORK, Dec. 19 (GenomeWeb News) - Nasdaq moved Clinical Data's exchange listing from the Capital Market to the National Market, Clinical Data said today.
Clinical Data's shares began trading on the Nasdaq National Market this morning. The company's stock symbol, CLDA, remains the same.
The Nasdaq Capital Market was formerly known as the Nasdaq Small Cap Market.
According to Israel Stein, Clinical Data's president and CEO, the move will "build shareholder value" as the company continues to integrate Genaissance Pharmaceuticals and Icoria.